FdaApplication
NDA 021882
Identifiers
- fda_app_no: NDA021882
Properties
| Property | Value |
|---|---|
| applicant_name | NOVARTIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2005-11-02 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| EXJADE | DEFERASIROX | 125MG | TABLET, FOR SUSPENSION;ORAL |
| EXJADE | DEFERASIROX | 500MG | TABLET, FOR SUSPENSION;ORAL |
| EXJADE | DEFERASIROX | 250MG | TABLET, FOR SUSPENSION;ORAL |
3 products